SCHEMBL19620575

SCHEMBL19620575

NC1=C(OSCc2ccccc2)C(=O)C(c2ccco2)O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 7/20 0.36
MAPT P10636 7/20 0.36
ALDH1A1 P00352 5/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 6/20 0.34
MEN1 O00255 5/20 0.34
TSHR P16473 3/20 0.34
USP2 O75604 2/20 0.34
PLA2G1B P04054 1/20 0.34
MAPK1 P28482 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34
KDM4E B2RXH2 4/20 0.33
RUNX1 Q01196 1/20 0.33
CBFB Q13951 1/20 0.33
ADORA2A P29274 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
APEX1 P27695 2/20 0.33
ADORA2B P29275 1/20 0.32
FPR1 P21462 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620603 0.83 POLB (0.50) POLBMAPTALDH1A1KMT2AMAPK1
SCHEMBL19620514 0.81 KDM1A (0.33) POLBMAPTALDH1A1KDM4EHTT
SCHEMBL19620665 0.79 HCRTR1 (0.38) MAPTALDH1A1L3MBTL1NPSR1HTT
SCHEMBL19620533 0.78 MAPT (0.42) POLBMAPTALDH1A1L3MBTL1USP2
SCHEMBL19620542 0.78 POLB (0.42) POLBMAPTKMT2AMEN1KDM4E
SCHEMBL19620522 0.78 KDM4E (0.42) POLBMAPTALDH1A1L3MBTL1KMT2A
SCHEMBL19620675 0.78 MAPT (0.42) POLBMAPTALDH1A1KMT2AMEN1
SCHEMBL19620625 0.78 CYP1A2 (0.34) POLBMAPTALDH1A1TSHRMAPK1
SCHEMBL19620528 0.78 DPP4 (0.36) POLBMAPTTSHRKDM4E
SCHEMBL19620732 0.77 MEN1 (0.33) POLBMAPTALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2021-01-20 EP disclosed
EP-3345596-A2 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2018-07-11 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed